🇺🇸 FDA
Pipeline program

EXENATIDE

Phase 2 small_molecule active

Quick answer

EXENATIDE for Gestational diabetes is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Gestational diabetes
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials